These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Shen X, Söderholm J, Lin F, Kobinger G, Bello A, Gregg DA, Broderick KE, Sardesai NY. Vaccine; 2012 Nov 06; 30(48):6946-54. PubMed ID: 22406460 [Abstract] [Full Text] [Related]
28. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice. Chen J, Liu Q, Chen Q, Xiong C, Yao Y, Wang H, Wang H, Chen Z. Arch Virol; 2014 Apr 06; 159(4):689-700. PubMed ID: 24132721 [Abstract] [Full Text] [Related]
30. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z. J Virol Methods; 2008 Dec 06; 154(1-2):121-7. PubMed ID: 18789973 [Abstract] [Full Text] [Related]
31. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice. Caillet C, Piras F, Bernard MC, de Montfort A, Boudet F, Vogel FR, Hoffenbach A, Moste C, Kusters I. Vaccine; 2010 Apr 19; 28(18):3076-9. PubMed ID: 20193791 [Abstract] [Full Text] [Related]
32. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus. Szécsi J, Gabriel G, Edfeldt G, Michelet M, Klenk HD, Cosset FL. J Infect Dis; 2009 Jul 15; 200(2):181-90. PubMed ID: 19505256 [Abstract] [Full Text] [Related]
35. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. PLoS Med; 2007 Feb 15; 4(2):e59. PubMed ID: 17298168 [Abstract] [Full Text] [Related]
36. Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity. Ohba K, Yoshida S, Zahidunnabi Dewan M, Shimura H, Sakamaki N, Takeshita F, Yamamoto N, Okuda K. Vaccine; 2007 May 22; 25(21):4291-300. PubMed ID: 17403560 [Abstract] [Full Text] [Related]
38. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related]
39. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. Lalor PA, Webby RJ, Morrow J, Rusalov D, Kaslow DC, Rolland A, Smith LR. J Infect Dis; 2008 Jun 15; 197(12):1643-52. PubMed ID: 18513153 [Abstract] [Full Text] [Related]
40. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Jang YH, Lee EY, Byun YH, Jung EJ, Lee YJ, Lee YH, Lee KH, Lee J, Seong BL. Vaccine; 2014 Jan 23; 32(5):535-43. PubMed ID: 24342248 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]